[The 20 mcg ethinylestradiol and 150 mcg desogestrel pill: six month, multicenter study in 235 women].
Serfaty
D
D
D001723:Birth Rate; D003267:Contraception; D003268:Contraception Behavior; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D003710:Demography; D019049:Developed Countries; D004997:Ethinyl Estradiol; D005060:Europe; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D005298:Fertility; D005602:France; D010342:Patient Acceptance of Health Care; D011153:Population; D011157:Population Dynamics; D018873:Pregnancy Rate
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D004997:Ethinyl Estradiol
Contraception; Contraception Continuation; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Methods; Contraceptive Usage; Demographic Factors; Developed Countries; Ethinyl Estradiol; Europe; Evaluation; Family Planning; Fertility; Fertility Measurements; France; Mediterranean Countries; Method Acceptability; Oral Contraceptives; Oral Contraceptives, Combined; Population; Population Dynamics; Pregnancy Rate; Western Europe